Posted on May 6th, 2008
PLYMOUTH, Mass.----Harvest Technologies Corp. announced today that Claas Ludermann, MD, a specialist in vascular medicine, presented preliminary data at the 74th Annual Meeting of the German Society of Cardiology from a clinical trial being conducted at the Berlin Vascular Center of Franziskus Hospital under the direction of Berthold Amman, MD.
No user commented in " Early Study Results Show New Stem Cell Treatment Successfully Treats Critical Limb Ischemia (CLI) Patients (Business Wire via Yahoo! Finance) "
Follow-up comment rss or Leave a Trackback